腹水浓缩回输治疗顽固性腹水的临床分析  

Clinical analysis of refractory ascites treated with concentration of ascites and reinfusion

作　　者：史立华[1] 王慧[1] 张其胜[1] SHI Lihua, WANG Hui, ZHANG Qisheng （ Shanghai No. 1 people＇s Hospital branch, Digestive Medicine Dept 200081）

机构地区：[1]上海市第一人民医院分院消化内科,200081

出　　处：《社区卫生保健》2006年第3期212-213,216,共3页Journal of Community Healthcare

摘　　要：目的探讨体外腹水浓缩回输治疗顽固性腹水的临床意义。方法选择顽固性腹水的患者，予以腹穿使腹水经过体外浓缩再回输入腹腔。观察体重、腹围、血液生化，利尿剂使用量的变化。结果与治疗前相比，腹水浓缩回输后，体重、腹围明显下降，利尿剂使用量减少，血浆白蛋白升高，胆红素、INR、电解质、肾功能无明显变化。结论腹水浓缩回输腹腔治疗顽固性腹水，效果可靠，操作简单，并发症少，有利于提高患者的生活质量。Objective To observe the clinical outcome of patients with liver cirrhosis and refractory ascites treated with in vitro closed concentration and reinfusion. Method Patients with refractory ascites were treated with in vitro closed concentration and reinfusion. The body weight, waistline, serum biochemical indexes, dose of diuretic were observed. Results After treatment, the body weight, waistline and dose of diuretic were declined compared with before treatment. Serum albumin was highter in patients with in vitro closed concentration and reinfusion than before. No change could be detected in bilirubin, INR, serum electrolyte and kidney function. Conelusion In vitro closed concentration and reinfusion is a very simple and convenient way in patients with liver cirrhosis and benificial to enhance patients quality of life.

关 键 词：顽固性腹水 浓缩回输 肝硬化 

分 类 号：R459.5[医药卫生—治疗学;医药卫生—临床医学] R442.5[医药卫生—诊断学;医药卫生—临床医学]